company background image
300009 logo

Anhui Anke Biotechnology (Group) XSEC:300009 Stock Report

Last Price

CN¥9.13

Market Cap

CN¥15.3b

7D

-3.7%

1Y

-13.7%

Updated

04 Nov, 2024

Data

Company Financials +

Anhui Anke Biotechnology (Group) Co., Ltd.

XSEC:300009 Stock Report

Market Cap: CN¥15.3b

300009 Stock Overview

Anhui Anke Biotechnology (Group) Co., Ltd.

300009 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth2/6
Past Performance3/6
Financial Health6/6
Dividends6/6

Anhui Anke Biotechnology (Group) Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Anhui Anke Biotechnology (Group)
Historical stock prices
Current Share PriceCN¥9.13
52 Week HighCN¥11.77
52 Week LowCN¥7.41
Beta0.56
11 Month Change-7.12%
3 Month Change5.31%
1 Year Change-13.71%
33 Year Change-27.37%
5 Year Change-8.64%
Change since IPO10.68%

Recent News & Updates

Recent updates

Shareholder Returns

300009CN BiotechsCN Market
7D-3.7%-4.1%-1.2%
1Y-13.7%-16.9%3.1%

Return vs Industry: 300009 exceeded the CN Biotechs industry which returned -16.9% over the past year.

Return vs Market: 300009 underperformed the CN Market which returned 3.1% over the past year.

Price Volatility

Is 300009's price volatile compared to industry and market?
300009 volatility
300009 Average Weekly Movement6.8%
Biotechs Industry Average Movement8.9%
Market Average Movement7.9%
10% most volatile stocks in CN Market12.0%
10% least volatile stocks in CN Market5.4%

Stable Share Price: 300009 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 300009's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20002,986Lihua Songwww.ankebio.com

Anhui Anke Biotechnology (Group) Co., Ltd. develops, produces, and markets pharmaceutical products in China and internationally. The company offers human growth hormone for injection under the Ansomone name; and recombinant human interferon alpha 2b lyophilized powder, liquid, and prefilled syringe for injection, as well as recombinant human interferon alpha 2b cream, eye drop, and suppository under the Anterferon name.

Anhui Anke Biotechnology (Group) Co., Ltd. Fundamentals Summary

How do Anhui Anke Biotechnology (Group)'s earnings and revenue compare to its market cap?
300009 fundamental statistics
Market capCN¥15.27b
Earnings (TTM)CN¥782.53m
Revenue (TTM)CN¥2.77b

19.5x

P/E Ratio

5.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300009 income statement (TTM)
RevenueCN¥2.77b
Cost of RevenueCN¥618.84m
Gross ProfitCN¥2.15b
Other ExpensesCN¥1.36b
EarningsCN¥782.53m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.47
Gross Margin77.62%
Net Profit Margin28.29%
Debt/Equity Ratio0.1%

How did 300009 perform over the long term?

See historical performance and comparison

Dividends

2.7%

Current Dividend Yield

53%

Payout Ratio